We investigated the clinical features and mode of disease progression in 142 patients with probable multiple system atrophy (MSA) according to the Consensus Criteria. The subjects included 84 men and 58 women with a mean age at onset of 58.2 ± 7.1 years (range: 38-79 years). Cerebellar signs were detected in 87.3% of these patients at the time of initial examination, and were found in 95.1% of them at latest follow-up. MSA-C was diagnosed in 83.8% of the patients at their first examination.
mentioned it in a patient's medical record or when the physician detected it by asking the patient, spouse, or children questions about the presence of certain symptoms ( neurogenic bladder, snoring, stridor, dyspnea and impotence ). Motor symptoms included either parkinsonism or cerebellar ataxia, and consisted of gait disturbance, clumsiness of the upper extremities, dysarthria, and tremor. In patients who reached the advanced stage, we classified the clinical phenotype by considering whether parkinsonism or cerebellar ataxia provided a greater obstacle to daily activities. We examined each patient at least every six months and we evaluated the parameters mentioned above, including the activities of daily life (ADL), from information in each patient's medical record. In 109 patients (76.8%), brain MRI was performed to acquire T 1 -and T 2 -weighted axial images [2, ,000 ms repetition time ( TR), 80-120 ms echo time (TE), 5-8 mm slice thickness and 1-2.5 mm interslice gap].
Statistical analysis
The Mann-Whitney U test was used to compare continuous variables between two subgroups. Contingency tables were analyzed by Fisher's exact test when the smallest expected value was < 5 or the chi-square test when the smallest expected value was > 5.
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All tests were two-sided, and significance was set at p < 0.05. We used the StatView version 4.5 statistical software package for these calculations.
Results

Profile of the MSA Patients
There were 84 men and 58 women. The mean age at onset of the first reported symptom was 58.2 ± 7.1 years (range; 38-79 years) and the mean follow-up period was 2.5 ± 1.7 years (range; 1-13 years). A total of 119 patients (83.8%) were initially classified as having MSA-C and 23 patients (16.2%) were classified as having MSA-P.
The overall gender distribution (male : female) was 1.4 : 1, while it was 1.5 : 1 in MSA-C and 1.1 : 1 in MSA-P. There were no significant differences between the two types of MSA with regard to the age at onset and the follow-up period.
Clinical features
Initial symptoms
One hundred and seven patients (75.4%) complained of motor dysfunction as the Yabe et al. -11 initial symptom (Table 1) , while only 22.5% of the patients had autonomic problems.
Gait disturbance was the most common symptom (62.2%), while 12.0% of the patients complained of neurogenic bladder and 9.9% had orthostatic hypotension. Interestingly, three patients (2.1%) initially presented with respiratory impairment and tracheotomy was performed.
Autonomic failure
Symptoms of autonomic failure were present in 85.2% of the patients at initial examination ( Table 2) , and were detected in all of the patients at the time of latest follow-up (Table 3) . Among these symptoms, urinary dysfunction was the most common (90.1%). Orthostatic hypotension was found in 88.0% of the MSA patients, while dyshidrosis was present in 22.5% and constipation was found in 16.2%.
Cerebellar dysfunction
Cerebellar signs were detected in 87.3% of the patients at the time of initial examination ( Table 2) , and this increased to 95.1% at the latest follow-up (Table 3) . 
Parkinsonism
Parkinsonism was detected in 28.9% of the patients at initial examination ( Table 2) , but was present in 51.4% at the latest follow-up (Table 3) . Although parkinsonism was detected in 50 MSA-C patients (42.0%) at the latest follow-up, bradykinesia with rigidity was seen in only 27 of them (22.7%). Tremor was documented in 19.0% of all patients and 43.5% of MSA-P patients, but resting tremor was only observed in 6 out of 142 MSA patients (4.2%) and 3 out of 23 MSA-P (13.0%).
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In most of the patients, levodopa therapy did not alleviate these symptoms. Among the 37 patients who were prescribed levodopa, only 8 (21.6%) responded well during the early phase of therapy, but three of them subsequently became poor responders. One of these 3 patients had MSA-C and the other two had MSA-P.
Respiratory dysfunction
Respiratory dysfunction was evident in 33.8% of the MSA patients. Laryngoscopy revealed vocal cord paralysis in most of them and tracheotomy had to be performed in 7.0% (Table 3 ).
Other clinical features
Pyramidal tract signs, such as an extensor planter response and hyperreflexia, were detected in 67.6% and 33.1% of the MSA patients, respectively (Table 3) .
Abnormal ocular movements ( in addition to nystagmus ) were seen in response to saccadic pursuits in 19.7% of the patients. Vibration sensation was decreased in the lower extremities of 21.8% of the patients. (Table 4 ). There were no significant differences in the frequency of signal abnormalities between the images obtained with the 1.5 T and 0.5 T MRI scanners ( data not shown ). Signal abnormalities became more frequent as the duration of disease increased ( Table 5 ).
Changes of clinical features
We followed 65 patients with MSA-C for at least 3 years. At the initial examination, parkinsonism was only detected in 15.4% of these patients, but it was 
Survial
Nineteen patients ( 14 men and 5 women ) died during the data collection period, but autopsies was not performed on any of them. Their mean age at onset was 58.2 ± 6.5 years (range; 45-74 years) and their mean duration of disease was 7.2 ± 3.9 years (range; 1-27 years). Sudden death occurred in 4 of these patients, and the mean time from onset to death was 4.5 ± 2.0 years (range; 2-7 years). All patients were initially classified as having MSA-C, with initial parkinsonism being detected in only 5 of them (26.3%). At the latest follow-up, however, parkinsonism was present in 12 of these patients (63.2%) and parkinsonian features had become dominant in 5 of them (26.3%).
On the other hand, parkinsonism was never detected in the other 7 patients (36.8%).
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Discussion
One hundred and nineteen (83.8%) of our 142 patients with probable MSA were initially classified as having MSA-C, which was a much more frequent manifestation of MSA than MSA-P (16.2%). In another series, 155 (67%) out of 230 Japanese MSA patients were classified as having MSA-C [17] . Therefore, MSA-C is considered to be the most common initial manifestation of MSA in the Japanese population. In contrast, parkinsonism is predominant from the onset among Caucasian MSA patients [3, 7, 13, 15] . One study performed in Germany showed that the frequency of MSA-C was higher than that of MSA-P [16] , but there may have been some bias in this epidemiological study because it was mainly based on neuroimaging data.
In addition to the differences in the initial presentation of MSA patients, further differences emerged as the disease progressed. By the time of latest follow-up, parkinsonian features had become dominant over the cerebellar features in 24.6% of 65 patients with MSA-C who were followed for more than 3 years. Only a few authors have previously described this clinical transition of MSA [18, 19] . A change of clinical MSA also varies among different ethnic populations [3, 7, 15, 17] , suggesting that differences of the genetic background or environmental factors can influence the phenotype, clinical features, and progression of MSA. Although no association has been found between MSA and polymorphism of the -synuclein, synphilin, tau, APOE, Fragile X, and brain-derived neurotrophic factor genes [20, 21, 22, 23] , polymorphism of the interleukin-1A, interleukin-1B, interleukin-8, intercellular adhesion molecule-1, tumor necrosis factor, and alpha-1-antichymotrypsin genes has been reported to increase the risk of MSA [24, 25, 26, 27, 28] . In addition, a few familial cases of MSA have recently been reported [29, 30] . it is possible that environmental factors also influenced their clinical features.
In this series, the frequency of neruogenic bladder at an early stage and impotence was relatively low compared with several previous reports [12, 14] . However, this result may have been biased because it was determined by asking questions and by retrospective review of each patient's medical record.
According to the current criteria [1] , probable MSA is diagnosed clinically in patients who have parkinsonism with a poor response to levodopa plus autonomic dysfunction or cerebellar ataxia plus autonomic dysfunction. Physicians who specialize in ataxia tend to diagnose patients with sporadic cerebellar ataxia as having MSA-C because some patients with sporadic olivopontocerebellar atrophy eventually develop MSA [34].
However, our data were not skewed by a special interest in cerebellar disorders, because none of our patients were seen at cerebellar units, and instead were assessed at the general neurology ward or outpatient clinic. Other disorders associated with parkinsonism, such as Parkinson's disease with autonomic failure, progressive supranuclear palsy (PSP), and diffuse Lewy body disease (DLBD), may often be misdiagnosed as MSA-P [7, 8, 9, 10, 11, 12] . A neuropathological study showed that Besides MRI, myocardial iodine-123 meta-iodobenzylguanidine (MIBG) scintigraphy is also useful for distinguishing between Parkinson's disease, DLBD, and MSA, since Legends Table 1 . In Table 2 . Neurological findi Table 3 . Clinical features at the latest follow-up Table 4 . Characteristic MRI findings Table 5 . Disease duration and frequenc 
